← Insider buys

TCMD

Tactile Systems Technology, Inc. · Healthcare

Insiders sold $2.0M of Tactile Systems Technology, Inc. in the last 12 months and bought none

$0Bought, 12 mo
$2.0MSold, 12 mo
$508.3MMarket cap

TCMD over the last year

No insider buys filed in this year

TCMD after insider buys

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Congress

Members reported 2 trades in TCMD since 2023.

Every filing

226 insider filings since 2016, newest first

TCMDSell

Bryan Rishe · SVP, Sales

$309K−9.0%Dec 12
TCMDSell

Bryan Rishe · SVP, Sales

$298K−9.0%Nov 27
TCMDSell

Robert J. Folkes · COO

$259K−6.0%Nov 25
TCMDSell

Bryan Rishe · SVP, Sales

$248K−9.0%Nov 13
TCMDSell

Robert J. Folkes · COO

$108K−3.0%Nov 12
TCMDSell

Bryan Rishe · SVP, Sales

$216K−9.0%Oct 30
TCMDSell

Robert J. Folkes · COO

$96K−3.0%Oct 28
TCMDSell

Robert J. Folkes · COO

$89K−3.0%Oct 15
TCMDSell

Bryan Rishe · SVP, Sales

$205K−9.0%Oct 15
TCMDSell

Robert J. Folkes · COO

$95K−3.0%Sep 30
TCMDSell

Bryan Rishe · SVP, Sales

$220K−9.0%Sep 27
TCMDSell

Robert J. Folkes · COO

$106K−3.0%Sep 16
TCMDSell

Bryan Rishe · SVP, Sales

$234K−9.0%Sep 12
TCMDSell

Richard Nigon · Director

$493K−8.0%Sep 11
TCMDSell

Richard Nigon · Director

$96K−2.0%Sep 6
TCMDSell

Bryan Rishe · SVP, Sales

$234K−9.0%Aug 28
TCMDSell

Robert J. Folkes · COO

$107K−2.0%Aug 26
TCMDSell

Kevin H Roche · Director

$254K−12.0%Aug 26
TCMDSell

Bryan Rishe · SVP, Sales

$234K−9.0%Aug 14
TCMDSell

Robert J. Folkes · COO

$108K−2.0%Aug 12
TCMDSell

Robert J. Folkes · COO

$115K−2.0%Jul 29
TCMDSell

Bryan Rishe · SVP, Sales

$261K−9.0%Jul 29
TCMDSell

Robert J. Folkes · COO

$116K−2.0%Jul 15
TCMDSell

Bryan Rishe · SVP, Sales

$266K−9.0%Jul 12
TCMDSell

Robert J. Folkes · COO

$110K−2.0%Jul 1
TCMDSell

Bryan Rishe · SVP, Sales

$259K−9.0%Jun 27
TCMDSell

Robert J. Folkes · COO

$118K−2.0%Jun 24
TCMDSell

William W Burke · Director

$550K−73.0%Jun 20
TCMDSell

Robert J. Folkes · COO

$266K−5.0%Jun 13
TCMDSell

Bryan Rishe · SVP, Sales

$256K−9.0%Jun 12
TCMDSell

Kevin H Roche · Director

$245K−11.0%Jun 3
TCMDSell

Robert J. Folkes · COO

$530K−10.0%May 23
TCMDSell

Richard Nigon · Director

$755K−11.0%May 17
TCMDSell

Bryan Rishe · SVP, Sales

$151K−6.0%May 17
TCMDSell

Robert J. Folkes · COO

$126K−2.0%May 17
TCMDSell

Robert J. Folkes · COO

$134K−2.0%May 14
TCMDSell

Kevin H Roche · Director

$578K−18.0%May 13
TCMDSell

Robert J. Folkes · COO

$256K−4.0%Apr 18
TCMDSell

Bryan Rishe · SVP, Sales

$159K−6.0%Apr 17
TCMDSell

Robert J. Folkes · COO

$330K−4.0%Mar 14
TCMDSell

Robert J. Folkes · COO

$210K−1.0%Mar 4
TCMDSell

Gerald R. Mattys · CEO

$2.0M−9.0%Mar 4
TCMDSell

Bryan Rishe · SVP, Sales

$208K−5.0%Feb 20
TCMDSell

Gerald R. Mattys · CEO

$3.5M−15.0%Feb 19
TCMDSell

Robert J. Folkes · COO

$347K−4.0%Feb 13
TCMDSell

Robert J. Folkes · COO

$201K−3.0%Feb 5
TCMDSell

Bryan Rishe · SVP, Sales

$178K−5.0%Jan 17
TCMDSell

Robert J. Folkes · COO

$301K−4.0%Jan 17
TCMDSell

Maggie Thompson · SVP, Reimb., Payer Relations

$958K−62.0%Jan 10
TCMDSell

Robert J. Folkes · COO

$138K−3.0%Jan 3
About Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.